ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,406Medicare Part D Prescriptions Filled, Including Refills

Rank: 37 out of 6969

$1.88M Total Retail Price of All Prescriptions

Rank: 38 out of 6969

613 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 613 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 613 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 17,930 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LEVOTHYROXINE SODIUM 1,543 1,049 1 5
SIMVASTATIN 964 642 2 1
FUROSEMIDE 929 686 3 10
LISINOPRIL 795 526 4 2
HYDROCODONE-ACETAMINOPHEN 735 553 S3 5 3
AMLODIPINE BESYLATE 565 363 6 4
OMEPRAZOLE 550 342 7 6
POTASSIUM CHLORIDE 471 403 8 30
METOPROLOL TARTRATE 415 272 9 13
METFORMIN HCL 403 238 10 7
DONEPEZIL HCL 390 370 11 32
SPIRIVA 366 233 12 66
GABAPENTIN 329 239 13 17
RISPERIDONE 316 178 14 88
LANTUS 316 233 14 50
DIVALPROEX SODIUM 302 225 16 103
LACTULOSE 283 150 17 131
BENZTROPINE MESYLATE 270 98 R 18 177
RISPERDAL CONSTA 270 153 18 380
ADVAIR DISKUS 252 181 20 45
SERTRALINE HCL 245 125 21 38
NAMENDA 243 243 22 51
NIASPAN 241 128 23 146
CARVEDILOL 233 184 24 25
ATENOLOL 233 146 24 9
MIRTAZAPINE 232 215 26 76
CLONIDINE HCL 232 138 26 59
TAMSULOSIN HCL 231 148 28 23
HYDROCHLOROTHIAZIDE 224 154 29 8
FAMOTIDINE 221 168 30 37
NOVOLOG 218 186 31 166
HALOPERIDOL 207 112 32 244
WARFARIN SODIUM 206 173 33 20
OXYBUTYNIN CHLORIDE ER 196 165 34 165
NOVOLIN R 192 163 35 161
QUETIAPINE FUMARATE 190 143 36 101
OLANZAPINE 185 123 37 139
GLYBURIDE 183 115 R 38 54
CARBIDOPA-LEVODOPA 180 146 39 119
FENTANYL 179 146 S2 40 113
RAMIPRIL 175 147 41 112
TRAMADOL HCL 160 137 42 27
METOPROLOL SUCCINATE 149 80 43 22
BENAZEPRIL HCL 147 78 44 18
GLIPIZIDE 145 110 45 21
ZOLPIDEM TARTRATE 144 104 46 16
LEVETIRACETAM 144 89 46 128
LOSARTAN POTASSIUM 143 54 48 12
CLOPIDOGREL 136 108 49 48
DIVALPROEX SODIUM ER 131 54 50 229
ESCITALOPRAM OXALATE 129 92 51 93
KLOR-CON M20 125 69 52 201
FLUOCINONIDE 123 96 53 134
TRIHEXYPHENIDYL HCL 122 47 R 54 459
FLUTICASONE PROPIONATE 119 61 55 24
VALPROIC ACID 118 84 56 234
HALOPERIDOL DECANOATE 116 43 57 395
FLUOXETINE HCL 116 62 57 43
HYDROXYZINE HCL 115 79 R 59 159
PHENYTOIN SODIUM EXTENDED 112 86 60 169
OXYBUTYNIN CHLORIDE 108 65 61 126
CITALOPRAM HBR 105 83 62 34
OLANZAPINE ODT 103 60 63 454
PLAVIX 102 83 64 68
COMBIVENT 101 28 65 170
SINGULAIR 101 77 65 84
BACLOFEN 100 50 67 86
ROPINIROLE HCL 99 96 68 162
PROPRANOLOL HCL 97 45 69 153
LATANOPROST 96 80 70 268
DIGOXIN 95 90 71 71
LEVOFLOXACIN 95 86 71 109
NYSTOP 94 73 73 329
HUMALOG 93 65 74 167
IPRATROPIUM-ALBUTEROL 93 85 74 212
FENOFIBRATE 90 21 76 63
PRAVASTATIN SODIUM 89 67 77 19
SEROQUEL 87 64 78 205
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 70 78 114
RANITIDINE HCL 85 46 80 46
PERMETHRIN 83 54 81 331
ISOSORBIDE DINITRATE 83 65 81 231
PREDNISONE 82 75 83 70
KLOR-CON 8 82 49 83 104
HYDRALAZINE HCL 80 40 85 106
KLOR-CON M10 79 37 86 257
ATORVASTATIN CALCIUM 78 34 87 11
ISOSORBIDE MONONITRATE ER 77 72 88 81
CARBAMAZEPINE 77 63 88 204
EXELON 77 74 88 157
ENALAPRIL MALEATE 75 68 91 56
ALENDRONATE SODIUM 74 64 92 14
LITHIUM CARBONATE 73 27 93 327
IBUPROFEN 72 32 94 29
ACTOS 71 35 95 61
SPIRONOLACTONE 71 45 95 102
INVEGA SUSTENNA 71 33 95 456
CYMBALTA 70 36 98 72
DIOVAN 69 47 99 26
AMIODARONE HCL 68 62 100 184
AMOXICILLIN 68 36 100 99
NITROGLYCERIN PATCH 67 67 102 256
LAMOTRIGINE 67 16 102 221
TRAZODONE HCL 64 43 104 47
STROMECTOL 64 48 104 400
KETOCONAZOLE 63 58 106 185
AGGRENOX 62 62 107 270
HALOPERIDOL LACTATE 62 0 107 472
ABILIFY 62 15 107 173
PANTOPRAZOLE SODIUM 61 37 110 31
ALLOPURINOL 59 54 111 35
TRIAMCINOLONE ACETONIDE 59 43 111 55
VENTOLIN HFA 58 26 113 125
ACETAMINOPHEN-CODEINE 58 53 S3 113 73
CLONIDINE 56 56 115 356
NIFEDIPINE ER 55 45 116 95
DILTIAZEM 24HR CD 54 47 117 191
MEGESTROL ACETATE 53 52 R 118 129
CEPHALEXIN 53 44 118 96
CLOZAPINE 52 0 120 309
DETROL LA 52 35 120 223
ALBUTEROL SULFATE 51 47 122 123
METHADONE HCL 50 0 S2 123 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 20, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.